| Drug Name |
Dalteparin sodium |
| Drug ID |
BADD_D00575 |
| Description |
Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant. It is composed of strongly acidic sulphated polysaccharide chains with an average molecular weight of 5000 and about 90% of the material within the range of 2000-9000. LMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin. |
| Indications and Usage |
It is also used in the prevention of clotting during hemodialysis and hemofiltration in connection with acute renal failure or chronic renal insufficiency. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
B01AB04 |
| DrugBank ID |
DB06779
|
| KEGG ID |
D03353
|
| MeSH ID |
D017985
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0069-0217; 0069-0228; 0069-0195; 0069-0206; 0069-0220; 0069-0196; 0069-0223; 0069-0232 |
| Synonyms |
Dalteparin | Tedelparin | FR-860 | FR 860 | FR860 | Kabi-2165 | Kabi 2165 | Kabi2165 | Dalteparin Sodium | Sodium, Dalteparin | Fragmin | Fragmine |
